Posterior hypoperfusion in parkinson's disease with and without dementia measured with arterial spin labeling MRI

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 4, 2011, Pages 803-807

  Kamagata, Koji ^a   Motoi, Yumiko ^a   Hori, Masaaki ^a   Suzuki, Michimasa ^a   Nakanishi, Atsushi ^a   Shimoji, Keigo ^a   Kyougoku, Shinsuke ^a   Kuwatsuru, Ryohei ^a   Sasai, Keisuke ^a   Abe, Osamu ^b   Mizuno, Yoshikuni ^a   Aoki, Shigeki ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial spin labeling; Parkinson's disease; Posterior cortex

Indexed keywords

AGED; ARTERY SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SPIN LABELING;

AGED; ARTERIES; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGY; PARKINSON DISEASE; SPIN LABELS;

EID: 79953248554     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22515     Document Type: Article

References (29)

1. Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-536. (Pubitemid 36543283)
2. Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 2000;920:16-27. (Pubitemid 32056547)
3. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-422. (Pubitemid 36379360)
4. Borghammer P, Chakravarty M, Jonsdottir KY, et al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct 2010;214:303-317.
5. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-130. (Pubitemid 28345371)
6. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.
7. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, Part 1. Technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228-1234.
8. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-859. (Pubitemid 40250829)
9. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100. (Pubitemid 30033655)
10. Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67:1215-1220. (Pubitemid 44563830)
11. Rule RR, Schuff N, Miller RG, Weiner MW. Gray matter perfusion correlates with disease severity in ALS. Neurology 2010;74:821-827.
12. Dashjamts T, Yoshiura T, Hiwatashi A, et al. Asymmetrical cerebral perfusion demonstrated by noninvasive arterial spin-labeling perfusion imaging in a patient with corticobasal degeneration. Jpn J Radiol 2010;28:75-78.
13. Petersen ET, Lim T, Golay X. Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 2006;55:219-232. (Pubitemid 43238088)
14. Petersen ET, Mouridsen K, Golay X. The QUASAR reproducibility study, Part II. Results from a multi-center arterial spin labeling test-retest study. Neuroimage 2010;49:104-113.
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 2008;64(Suppl 2):S81-S92.
18. Golay X, Petersen ET, Hui F. Pulsed star labeling of arterial regions (PULSAR): a robust regional perfusion technique for high field imaging. Magn Reson Med 2005;53:15-21. (Pubitemid 40110472)
19. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148. (Pubitemid 23054795)
20. Yamamoto R, Iseki E, Murayama N, et al. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. J Neurol Sci 2006;246:95-101. (Pubitemid 43815344)
21. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125(Pt 2):391-403. (Pubitemid 34127441)
22. Parent A. Amygdala. Carpenter's human neuroanatomy. Baltimore: Williams and Wilkins; 1996.
23. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 1994;34:2629-2638. (Pubitemid 24256856)
24. Aiba I, Indo T, Takahashi A. [The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa-measurement by Xe-enhanced CT]. Rinsho Shinkeigaku 1994;34:1099-1104.
25. Henriksen L, Boas J. Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa. Acta Neurol Scand 1985;71:257-266.
26. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127(Pt 4):791-800. (Pubitemid 38478524)
27. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-1589. (Pubitemid 29471145)
28. Mito Y, Yoshida K, Yabe I, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg 2005;107:396-403. (Pubitemid 40980384)
29. Spampinato U, Habert MO, Mas JL, et al. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1991;54:787-792.